- Investing Ideas
- Taiwanese Pharmaceuticals & Biotech Top Stock Picks from Analysts
Taiwanese Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
8
Companies which are more than 50% undervalued based on analyst price target.
8 companies
Caliway Biopharmaceuticals
Market Cap: NT$168.1b
Engages in the development of drugs for aesthetic medicine and chronic inflammation.
6919
NT$109.00
7D
6.9%
1Y
-10.3%
Bora Pharmaceuticals
Market Cap: NT$49.9b
Engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally.
6472
NT$425.00
7D
12.4%
1Y
-40.1%
Lotus Pharmaceutical
Market Cap: NT$48.9b
Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.
1795
NT$189.00
7D
7.7%
1Y
-15.6%
Oneness Biotech
Market Cap: NT$22.7b
Engages in the research, development, and sale of new drugs, pharmaceuticals, and health products in Taiwan.
4743
NT$45.80
7D
8.4%
1Y
-32.7%
TaiMed Biologics
Market Cap: NT$15.7b
A biotechnology company, develops, manufactures, and commercializes drugs for the treatment and prevention of infectious diseases.
4147
NT$59.10
7D
4.6%
1Y
-29.2%
Medigen Vaccine Biologics
Market Cap: NT$15.6b
A biotechnology drug company, engages in the research, development, and wholesale of vaccines and biopharmaceuticals, and medical devices in Taiwan.
6547
NT$52.10
7D
14.0%
1Y
21.9%
EirGenix
Market Cap: NT$14.4b
Operates as a contract development and manufacturing company in Taiwan and internationally.
6589
NT$48.60
7D
6.0%
1Y
-22.2%
Foresee Pharmaceuticals
Market Cap: NT$12.5b
Operates as biopharmaceutical company in the United States, China, and Europe.
6576
NT$79.30
7D
0.4%
1Y
0%